Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 03, 2022	Apr. 04, 2021
Operating activities:
Net income	$ 176,962	$ 379,305
Loss from discontinued operations and dispositions, net of income taxes	41	38
Income from continuing operations	177,003	379,343
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:
Restructuring and other costs, net	13,384	5,744
Depreciation and amortization	120,052	70,186
Stock-based compensation	15,262	5,157
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	693	240
Amortization of deferred debt financing costs and accretion of discounts and debt extinguishment costs	1,900	896
Change in fair value of financial securities	12,125	(19,298)
Amortization of acquired inventory revaluation	16,868	2,981
Changes in operating assets and liabilities which provided (used) cash, excluding effects from companies purchased and divested:
Accounts receivable, net	69,065	165,190
Inventories	(46,968)	(15,008)
Accounts payable	26,352	(5,048)
Increase (Decrease) in Accrued Expenses and Other	(122,521)	(116,883)
Net cash provided by operating activities	283,215	473,500
Investing activities:
Capital expenditures	(29,431)	(14,311)
Payments to Acquire Investments	(22,995)	(4,000)
Cash paid for acquisitions, net of cash, cash equivalents and restricted cash acquired	(3,880)	(443,543)
Net cash used in investing activities	(56,306)	(461,854)
Financing activities:
Payments of borrowings	220,000	743,545
Proceeds from borrowings	220,000	584,000
Repayments of Term Loan	(100,000)	0
Proceeds from sale of senior debt	0	799,856
Payments of debt financing and equity issuance costs	0	(7,882)
Settlement of cash flow hedges	(762)	6,005
Net payments on other credit facilities	(1,064)	(9,799)
Proceeds from issuance of common stock under stock plans	1,397	4,987
Purchases of common stock	(55,592)	(42,779)
Dividends paid	(8,837)	(7,852)
Net cash provided by (used in) financing activities	(164,858)	582,991
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(10,636)	(6,849)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalent	51,415	587,788
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at beginning of period	619,337	402,613
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at end of period	670,752	990,401
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]
Cash and cash equivalents	669,755	988,234
Restricted Cash, Current	997	2,167
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 670,752	$ 990,401